Cargando…
Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases
INTRODUCTION: CLBQ14, a derivative of 8-hydroxyquinoline, exerts its chemotherapeutic effect by inhibiting methionine aminopeptidase (MetAP), the enzyme responsible for the post-translational modification of several proteins and polypeptides. MetAP is a novel target for infectious diseases. CLBQ14 i...
Autores principales: | Ekpenyong, Oscar, Gao, Xiuqing, Ma, Jing, Cooper, Candace, Nguyen, Linh, Olaleye, Omonike A, Liang, Dong, Xie, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127848/ https://www.ncbi.nlm.nih.gov/pubmed/32280198 http://dx.doi.org/10.2147/DDDT.S238148 |
Ejemplares similares
-
The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis
por: Esa, Rawnaq, et al.
Publicado: (2020) -
Analysis of the stoichiometric metal activation of methionine aminopeptidase
por: Chai, Sergio C, et al.
Publicado: (2009) -
Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
por: Joharapurkar, Amit A, et al.
Publicado: (2014) -
MapB Protein is the Essential Methionine Aminopeptidase in Mycobacterium tuberculosis
por: Vanunu, Miriam, et al.
Publicado: (2019) -
Methionine aminopeptidase-2 is a pivotal regulator of vasculogenic mimicry
por: Shimizu, Shota, et al.
Publicado: (2022)